MedPath

University of Pittsburgh Brain Health Initiative

Recruiting
Conditions
Traumatic Brain Injury
Interventions
Diagnostic Test: Cognitive/Neuropsychological Testing
Diagnostic Test: Vestibular/Ocular-Motor Testing
Diagnostic Test: Sleep Evaluation
Diagnostic Test: MRI, High-Resolution
Diagnostic Test: Health & Physical Exam
Diagnostic Test: Physical Function
Diagnostic Test: Blood Testing and Biomarker Analysis
Diagnostic Test: Applanation Tonometry
Diagnostic Test: PET brain imaging
Drug: [C-11]6-OH-BTA-1
Drug: [F-18]AV-1451
Registration Number
NCT04708613
Lead Sponsor
David Okonkwo, MD, PhD
Brief Summary

This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Former Professional Football PlayersCognitive/Neuropsychological TestingFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersVestibular/Ocular-Motor TestingFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersSleep EvaluationFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersMRI, High-ResolutionFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersHealth & Physical ExamFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersPhysical FunctionFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Control GroupsCognitive/Neuropsychological TestingFriends and brothers of the Former Professional Football Player group.
Former Professional Football PlayersBlood Testing and Biomarker AnalysisFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersApplanation TonometryFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football PlayersPET brain imagingFormer professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football Players[C-11]6-OH-BTA-1Former professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Former Professional Football Players[F-18]AV-1451Former professional football players who played in at least 3 professional seasons, with at least 3 games each season.
Control GroupsBlood Testing and Biomarker AnalysisFriends and brothers of the Former Professional Football Player group.
Control GroupsVestibular/Ocular-Motor TestingFriends and brothers of the Former Professional Football Player group.
Control GroupsSleep EvaluationFriends and brothers of the Former Professional Football Player group.
Control GroupsMRI, High-ResolutionFriends and brothers of the Former Professional Football Player group.
Control GroupsHealth & Physical ExamFriends and brothers of the Former Professional Football Player group.
Control GroupsPhysical FunctionFriends and brothers of the Former Professional Football Player group.
Control GroupsApplanation TonometryFriends and brothers of the Former Professional Football Player group.
Control GroupsPET brain imagingFriends and brothers of the Former Professional Football Player group.
Control Groups[C-11]6-OH-BTA-1Friends and brothers of the Former Professional Football Player group.
Control Groups[F-18]AV-1451Friends and brothers of the Former Professional Football Player group.
Primary Outcome Measures
NameTimeMethod
Rates of Brain Health versus Cognitive Impairment1-week

The diagnosis of cognitive impairment is based on the ADRC National Alzheimer's Coordinating Center (NACC) criteria for mild cognitive impairment. This criteria is adjudicated following a comprehensive neuropsychological exam, and includes: (1) Self- or informant-reported cognitive complaint, (2) Objective cognitive impairment, (3) Preserved independence in functional abilities, and (4) No dementia.

Secondary Outcome Measures
NameTimeMethod
Clinical Syndromes of Neurodegeneration1-week

The determination of trauma-related neurodegeneration will be based on: 1) presence of cognitive deficits, and/or neuromotor manifestations, and/or behavioral/mood-related symptoms; 2) PET scans demonstrating abnormal amyloid and/or tau deposition; 3) quantitative MR evidence of cortical volume loss and/or white matter injury; and 4) elevated CSF tau/Aβ42 ratio.

These multiple measures will be combined to arrive at a single overall outcome measure. This will be adjudicated at a blinded Diagnostic Consensus Conference comprised of experts from each field.

Trial Locations

Locations (1)

University of Pittsburgh Department of Neurosurgery

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath